Cognition Therapeutics, Inc. (CGTX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
CGTX Insider Trading Activity
CGTX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $30,001 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Ricciardi Lisa | CEO & President | 2 | $39,976 | 0 | $0 | $39,976 |
About Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.
Insider Activity of Cognition Therapeutics, Inc.
Over the last 12 months, insiders at Cognition Therapeutics, Inc. have bought $30,001 and sold $0 worth of Cognition Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cognition Therapeutics, Inc. have bought $2.82M and sold $4,818 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ricciardi Lisa (CEO & President) — $39,976.
The last purchase of 38,851 shares for transaction amount of $30,001 was made by Ricciardi Lisa (CEO & President) on 2025‑01‑31.
List of Insider Buy and Sell Transactions, Cognition Therapeutics, Inc.
| 2025-01-31 | Ricciardi Lisa | CEO & President | 38,851 0.094% | $0.77 | $30,001 | -21.51% | ||
| 2024-03-14 | Ricciardi Lisa | CEO & President | 5,700 0.0172% | $1.75 | $9,975 | -60.21% | ||
| 2022-11-29 | RICHSTONE ELLEN B | director | 10,000 0.0453% | $2.65 | $26,550 | -29.84% | ||
| 2022-11-28 | Kreis Leslie W. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
| 2022-11-28 | Fletcher Aaron G.L. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
| 2022-11-16 | Kreis Leslie W. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.74% | ||
| 2022-11-16 | Fletcher Aaron G.L. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.74% | ||
| 2022-11-15 | Kreis Leslie W. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.69% | ||
| 2022-11-15 | Fletcher Aaron G.L. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.69% | ||
| 2022-11-15 | Wallace Peggy | director | 12,500 0.0438% | $1.20 | $15,000 | +20.69% | ||
| 2022-11-15 | Ricciardi Lisa | CEO & President | 12,000 0.0455% | $1.30 | $15,600 | +20.69% | ||
| 2021-10-13 | Sale | Ogden CAP Associates, LLC | 10 percent owner | 74.05 0.0014% | $12.00 | $889 | -76.39% | |
| 2021-10-13 | Sale | Golden Seeds Cognition Therapeutics LLC | 10 percent owner | 33.09 0.0006% | $12.00 | $397 | -76.39% | |
| 2021-10-13 | Sale | Breedlove Mark H. | director | 23.48 0.0004% | $12.00 | $282 | -76.39% | |
| 2021-10-13 | Sale | Fletcher Aaron G.L. | director | 180.56 0.0034% | $12.00 | $2,167 | -76.39% | |
| 2021-10-13 | Sale | BIOS Memory SPV I, LP | 10 percent owner | 90.28 0.0017% | $12.00 | $1,083 | -76.39% | |
| 2021-10-13 | Fletcher Aaron G.L. | director | 380,000 7.2005% | $12.00 | $4.56M | -76.39% | ||
| 2021-10-13 | BIOS Memory SPV I, LP | 10 percent owner | 190,000 3.6003% | $12.00 | $2.28M | -76.39% | ||
| 2021-10-13 | Ricciardi Lisa | CEO & President | 25,000 0.4737% | $12.00 | $300,000 | -76.39% | ||
| 2021-10-13 | O'Brien James Michael | Chief Financial Officer | 10,000 0.1895% | $12.00 | $120,000 | -76.39% |
Insider Historical Profitability
| Ricciardi Lisa | CEO & President | 38851 0.0935% | $17,381.94 | 4 | 0 | <0.0001% |
| Ogden CAP Associates, LLC | 10 percent owner | 2210377 5.3201% | $988,922.67 | 0 | 1 | |
| Golden Seeds Cognition Therapeutics LLC | 10 percent owner | 2177985 5.2421% | $974,430.49 | 0 | 1 | |
| Fletcher Aaron G.L. | director | 2021906 4.8664% | $904,600.74 | 4 | 1 | <0.0001% |
| Kreis Leslie W. | director | 2021906 4.8664% | $904,600.74 | 3 | 0 | +5.55% |
| BIOS Memory SPV I, LP | 10 percent owner | 899905 2.1659% | $402,617.50 | 1 | 1 | <0.0001% |
| Breedlove Mark H. | director | 404439 0.9734% | $180,946.01 | 0 | 1 | |
| Wallace Peggy | director | 37961 0.0914% | $16,983.75 | 2 | 0 | <0.0001% |
| RICHSTONE ELLEN B | director | 10000 0.0241% | $4,474.00 | 1 | 0 | <0.0001% |
| O'Brien James Michael | Chief Financial Officer | 5000 0.012% | $2,237.00 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$992,222,850 | 90 | -12.52% | $19.2M | |
$6,204,522 | 45 | 1.91% | $19.24M | |
$550,024 | 37 | -2.68% | $20.57M | |
$85,897,100 | 36 | 2.47% | $17.01M | |
$217,684 | 34 | 1.61% | $17.89M | |
$555,628 | 21 | 43.52% | $17.92M | |
$206,127 | 21 | -29.00% | $16.71M | |
$2,553,853 | 17 | 16.69% | $15.38M | |
$37,194,483 | 17 | -51.30% | $15.85M | |
Cognition Therapeutics, Inc. (CGTX) | $11,247,055 | 15 | -26.49% | $18.59M |
$79,536,861 | 15 | -6.81% | $19.95M | |
$474,020 | 10 | 23.32% | $19.93M | |
$31,401,303 | 6 | -34.20% | $21.92M | |
$2,060,158 | 5 | -21.35% | $16.73M | |
$1,028,395 | 4 | -11.91% | $18.32M | |
$25,999,992 | 4 | 13.36% | $22.07M | |
$45,953 | 2 | -2.16% | $17.7M | |
$5,512,500 | 1 | -7.91% | $19.29M | |
$30,190 | 1 | -42.39% | $20.6M |
CGTX Institutional Investors: Active Positions
| Increased Positions | 18 | +47.37% | 7M | +179.36% |
| Decreased Positions | 10 | -26.32% | 323,463 | -8.06% |
| New Positions | 7 | New | 7M | New |
| Sold Out Positions | <1 | Sold Out | 11,000 | Sold Out |
| Total Postitions | 46 | +21.05% | 11M | +171.3% |
CGTX Ownership Change vs Market
Institutional Investor Ownership
| Bios Capital Management, Lp | $2,730.00 | 14.29% | 6M | +6M | New | 2024-12-31 |
| Vanguard Group Inc | $564.00 | 2.95% | 1.24M | -2,987 | -0.24% | 2024-12-31 |
| Sigma Planning Corp | $280.00 | 1.46% | 614,490 | +417,300 | +211.62% | 2024-12-31 |
| Voss Capital, Lp | $228.00 | 1.19% | 500,000 | +500,000 | New | 2024-12-31 |
| Alyeska Investment Group, L.P. | $228.00 | 1.19% | 500,000 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $160.00 | 0.84% | 352,348 | +28,705 | +8.87% | 2024-12-31 |
| Cm Management, Llc | $91.00 | 0.48% | 200,000 | -50,000 | -20% | 2024-12-31 |
| Kestra Advisory Services, Llc | $81.00 | 0.42% | 177,434 | -11,000 | -5.84% | 2024-12-31 |
| Blackrock, Inc. | $71.00 | 0.37% | 156,039 | +494 | +0.32% | 2024-12-31 |
| State Street Corp | $55.00 | 0.29% | 121,850 | +59,100 | +94.18% | 2024-12-31 |